China-based ultrasound firm picks U.S. Medical as main distributor
SIUI moves into U.S. market and toward its own designs Medical equipment distributor U.S. Medical has formed a partnership with Shantou Institute of Ultrasonic Instruments to sell SIUI's ultrasound systems in the U.S. The two companies anticipate the
SIUI moves into U.S. market and toward its own designs
Medical equipment distributor U.S. Medical has formed a partnership with Shantou Institute of Ultrasonic Instruments to sell SIUI's ultrasound systems in the U.S. The two companies anticipate the deal will evolve into an exclusive relationship.
"SIUI is the largest ultrasound company in China. Their prices are generally much lower than other systems," said Craig Borman, U.S. Medical's vice president for medical diagnostics.
The China-based company has been selling ultrasound scanners for many years in Asia, Europe, and South America, according to SIUI's marketing director, James Ma, who said FDA clearance for five models has opened up the U.S. market.
"Our products are relatively inexpensive but have high value," Ma said.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.
